Printer's No. PN3874
See other bills
under the
same topic PRINTER'S NO. 3874 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2770 Session of 2026 INTRODUCED BY FRANKEL, RAPP, BENHAM, KRUPA, WAXMAN, VENKAT, D. WILLIAMS, KHAN, DEASY, HOWARD, POWELL, ROAE, ZIMMERMAN, STEELE, SANCHEZ, BOROWSKI, PASHINSKI AND INGLIS, SEPTEMBER 10, 2026 REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 14, 2026 AN ACTAmending the act of June 13, 1967 (P.L.31, No.21), entitled "An act to consolidate, editorially revise, and codify the public welfare laws of the Commonwealth," in public assistance, providing for drug cost transparency and pharmacy purchasing protections.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The act of June 13, 1967 (P.L.31, No.21), known as the Human Services Code, is amended by adding a section to read:Section 449.3. Drug Cost Transparency and Pharmacy Purchasing Protections.--(a) Each pharmacy enrolled in the medical assistance program and each distributor that supplies prescription drugs to a pharmacy enrolled in the medical assistance program shall submit to the department, in accordance with subsection (b), drug cost transparency reports related to drugs dispensed and distributed under the medical assistance program for the following purposes:123456789101112131415161718 (1) Identifying factors that impact pharmacy drug acquisition cost.(2) Improving transparency in the drug supply chain.(3) Understanding geographic differences in drug acquisition costs across this Commonwealth.(4) Enabling the department to analyze and make informed policy decisions.(5) Protecting pharmacies from distributor practices that disadvantage pharmacies.(b) A drug cost transparency report under subsection (a) shall be submitted in a manner, format and at a frequency as determined by the department, but no less than quarterly. The department shall determine the scope of drugs to be included in a report, the required drug and pricing data, including rebates and other discounts, and the method by which the report shall be submitted.(c) The following prohibitions shall apply to drugs distributed under the medical assistance program:(1) A distributor that supplies prescription drugs to a pharmacy enrolled in the medical assistance program may not:(i) Tie the purchase price of a brand name drug to the purchase volume of generic drugs.(ii) Offer, grant or apply any off-invoice rebate or allowance to an enrolled pharmacy for purchased drugs.(2) A pharmacy enrolled in the medical assistance program may not accept or receive from a distributor any off-invoice rebate or allowance for purchased drugs.(d) As used in this section, the following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:20260HB2770PN3874 - 2 - 123456789101112131415161718192021222324252627282930 "Discounts" means price reductions applied at the time of purchase, including volume purchasing, prompt pay and group purchasing."Distributor" shall have the same meaning as defined in section 2 of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act."Off-invoice rebate or allowance" means any reduction, deduction, subtraction or discount applied by a distributor directly to the gross billing amount on the face of the actual purchase invoice."Rebate" means the percentage of payment returned after the purchase.Section 2. This act shall take effect in 60 days.20260HB2770PN3874 - 3 - 12345678910111213
under the
same topic PRINTER'S NO. 3874 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2770 Session of 2026 INTRODUCED BY FRANKEL, RAPP, BENHAM, KRUPA, WAXMAN, VENKAT, D. WILLIAMS, KHAN, DEASY, HOWARD, POWELL, ROAE, ZIMMERMAN, STEELE, SANCHEZ, BOROWSKI, PASHINSKI AND INGLIS, SEPTEMBER 10, 2026 REFERRED TO COMMITTEE ON HEALTH, SEPTEMBER 14, 2026 AN ACTAmending the act of June 13, 1967 (P.L.31, No.21), entitled "An act to consolidate, editorially revise, and codify the public welfare laws of the Commonwealth," in public assistance, providing for drug cost transparency and pharmacy purchasing protections.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. The act of June 13, 1967 (P.L.31, No.21), known as the Human Services Code, is amended by adding a section to read:Section 449.3. Drug Cost Transparency and Pharmacy Purchasing Protections.--(a) Each pharmacy enrolled in the medical assistance program and each distributor that supplies prescription drugs to a pharmacy enrolled in the medical assistance program shall submit to the department, in accordance with subsection (b), drug cost transparency reports related to drugs dispensed and distributed under the medical assistance program for the following purposes:123456789101112131415161718 (1) Identifying factors that impact pharmacy drug acquisition cost.(2) Improving transparency in the drug supply chain.(3) Understanding geographic differences in drug acquisition costs across this Commonwealth.(4) Enabling the department to analyze and make informed policy decisions.(5) Protecting pharmacies from distributor practices that disadvantage pharmacies.(b) A drug cost transparency report under subsection (a) shall be submitted in a manner, format and at a frequency as determined by the department, but no less than quarterly. The department shall determine the scope of drugs to be included in a report, the required drug and pricing data, including rebates and other discounts, and the method by which the report shall be submitted.(c) The following prohibitions shall apply to drugs distributed under the medical assistance program:(1) A distributor that supplies prescription drugs to a pharmacy enrolled in the medical assistance program may not:(i) Tie the purchase price of a brand name drug to the purchase volume of generic drugs.(ii) Offer, grant or apply any off-invoice rebate or allowance to an enrolled pharmacy for purchased drugs.(2) A pharmacy enrolled in the medical assistance program may not accept or receive from a distributor any off-invoice rebate or allowance for purchased drugs.(d) As used in this section, the following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:20260HB2770PN3874 - 2 - 123456789101112131415161718192021222324252627282930 "Discounts" means price reductions applied at the time of purchase, including volume purchasing, prompt pay and group purchasing."Distributor" shall have the same meaning as defined in section 2 of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act."Off-invoice rebate or allowance" means any reduction, deduction, subtraction or discount applied by a distributor directly to the gross billing amount on the face of the actual purchase invoice."Rebate" means the percentage of payment returned after the purchase.Section 2. This act shall take effect in 60 days.20260HB2770PN3874 - 3 - 12345678910111213
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.